Literature DB >> 22204180

In vitro susceptibility of typhoidal Salmonellae against newer antimicrobial agents: a search for alternate treatment options.

Saba Qaiser1, Seema Irfan, Erum Khan, Tanwir Ahsan, Afia Zafar.   

Abstract

OBJECTIVES: To determine the minimum inhibitory concentrations (MICs) of ceftriaxone, azithromycin, pefloxacin, cefipime and imipenem for Salmonella Typhi (S. Typhi) and Paratyphi.
METHODS: One hundred and fifty four isolates of Salmonella Typhi and S. Paratyphi A, B and C growing in blood culture were selected. MICs of ceftriaxone, azithromycin, pefloxacin, cefipime and imipenem were performed by agar dilution method as recommended by clinical laboratory standard institutes.
RESULTS: MIC90 of azithromycin and pefloxacin was 8 microg/ml, cefipime was 0.06 microg/ml and imipenem was 0.5 microg/ml. None of the strains were found to be resistant to ceftriaxone but 3 isolates showed higher MIC value of 2 microg/ml.
CONCLUSION: Azithromycin appears a suitable alternate for the treatment of typhoid in the community. Imipenem and cefipime are good options in complicated cases to be treated in hospital settings. Pefloxacin cannot be used as MICs are higher. Presence of isolates with higher MIC of ceftriaxone is serious and stresses upon continuous laboratory surveillance to guide clinicians appropriately.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22204180

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  2 in total

1.  Antibiotic resistance in Pakistan: a systematic review of past decade.

Authors:  Hazrat Bilal; Muhammad Nadeem Khan; Tayyab Rehman; Muhammad Fazal Hameed; Xingyuan Yang
Journal:  BMC Infect Dis       Date:  2021-03-06       Impact factor: 3.090

2.  High prevalence of typhoidal Salmonella enterica serovars excreting food handlers in Karachi-Pakistan: a probable factor for regional typhoid endemicity.

Authors:  Taranum Ruba Siddiqui; Safia Bibi; Muhammad Ayaz Mustufa; Sobiya Mohiuddin Ayaz; Adnan Khan
Journal:  J Health Popul Nutr       Date:  2015-12-08       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.